US2015056698A1PendingUtilityA1

Primate embryonic stem cells

Assignee: WISCONSIN ALUMNI RES FOUNDPriority: Jan 20, 1995Filed: May 19, 2014Published: Feb 26, 2015
Est. expiryJan 20, 2015(expired)· nominal 20-yr term from priority
A61P 37/00A61P 3/10C12N 5/0606C12N 5/0605A61P 25/16C12N 2502/13C12N 2506/02C12N 5/0603
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A purified preparation of primate embryonic stem cells is disclosed. This preparation is characterized by the following cell surface markers: SSEA-1 (−); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); and alkaline phosphatase (+). In a particularly advantageous embodiment, the cells of the preparation are human embryonic stem cells, have normal karyotypes, and continue to proliferate in an undifferentiated state after continuous culture for eleven months. The embryonic stem cell lines also retain the ability, throughout the culture, to form trophoblast and to differentiate into all tissues derived from all three embryonic germ layers (endoderm, mesoderm and ectoderm). A method for isolating a primate embryonic stem cell line is also disclosed.

Claims

exact text as granted — not AI-modified
1 .- 26 . (canceled) 
     
     
         27 . A method of differentiating primate embryonic stem cells into derivatives of endoderm, the method comprising:
 (a) obtaining a culture of primate embryonic stem cells, wherein the primate embryonic stem cells have the potential to differentiate into derivatives of endoderm;   (b) culturing the primate embryonic stem cells so that they differentiate into derivatives of endoderm.

Join the waitlist — get patent alerts

Track US2015056698A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.